Endothelial progenitor cells as a new agent contributing to vascular repair

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 4, 2007, Pages 247-259

  Miller Kasprzak, Ewa ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Angiogenesis; Colony forming unit; Endothelial progenitor cells; Surface markers

Indexed keywords

C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CHEMOKINE; ERYTHROPOIETIN; ESTROGEN; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; LYMPHOCYTE SURFACE MARKER; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL TRANSPLANTATION; DIABETES MELLITUS; ENDOTHELIUM; EXERCISE; HUMAN; ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL; STEM CELL TRANSPLANTATION; VASCULAR DISEASE; VASCULAR SURGERY;

ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; ENDOTHELIAL CELLS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; STEM CELL TRANSPLANTATION; STEM CELLS; VASCULAR DISEASES;

EID: 34547866709     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0027-5     Document Type: Review

References (66)

1. Adams V., Lenk K., Linke A., Lenz D., Erbs S., Sandri M., Tarnok A., Gielen S., Emmrich F., Schuler G. and Hambrecht R. (2004): Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler. Thromb. Vasc. Biol., 24, 684-690.
2. Aghi M. and Chiocca E. A. (2005): Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol. Ther., 12, 994-1005.
3. Arafat W. O., Casado E., Wang M., Alvarez R. D., Siegal G. P., Glorioso J. C., Curiel D. T. and Gomez-Navarro J. (2000): Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells. Clin. Cancer Res., 6, 4442-4448.
4. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M. and Isner J. M. (1999): Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res., 85, 221-228.
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G. and Isner J. M. (1997): Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967.
6. Bahlmann F. H., De Groot K., Spandau J. M., Landry A. L., Hertel B., Duckert T., Boehm S. M., Menne J., Haller H. and Fliser D. (2004): Erythropoietin regulates endothelial progenitor cells. Blood, 103, 921-926.
7. Bahlmann F. H., De Groot K., Duckert T., Niemczyk E., Bahlmann E., Boehm S. M., Haller H. and Fliser D. (2003): Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int., 64, 1648-1652.
8. Byrne A. M., Bouchier-Hayes D. J. and Harmey J. H. (2005): Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J. Cell Mol. Med., 9, 777-794.
9. Cho H. J., Kim H. S., Lee M. M., Kim D. H., Yang H. J., Hur J., Hwang K. K., Oh S., Choi Y. J., Chae I. H., Oh B. H., Choi Y. S., Walsh K. and Park Y. B. (2003): Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation, 108, 2918-2925.
10. Choi J. H., Hur J., Yoon C. H., Kim J. H., Lee C. S., Youn S. W., Oh I. Y., Skurk C., Murohara T., Park Y. B., Walsh K. and Kim H. S. (2004): Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J. Biol. Chem., 279, 49430-49438.
11. De Groot K., Bahlmann F. H., Bahlmann E., Menne J., Haller H. and Fliser D. (2005): Kidney graft function determines endothelial progenitor cell number in renal transplant recipients. Transplantation, 79, 941-945.
12. De Groot K., Bahlmann F. H., Sowa J., Koenig J., Menne J., Haller H. and Fliser D. (2004): Uremia causes endothelial progenitor cell deficiency. Kidney Int., 66, 641-646.
13. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H. and Zeiher A. M. (2001): HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest., 108, 391-397.
14. Erbs S., Linke A., Adams V., Lenk K., Thiele H., Diederich K. W., Emmrich F., Kluge R., Kendziorra K., Sabri O., Schuler G. and Hambrecht R. (2005): Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ. Res., 97, 756-762.
15. Fina L., Molgaard H. V., Robertson D., Bradley N. J., Monaghan P., Delia D., Sutherland D. R., Baker M. A. and Greaves M. F. (1990): Expression of the CD34 gene in vascular endothelial cells. Blood, 75, 2417-2426.
16. Fraser J. K., Schreiber R., Strem B., Zhu M., Alfonso Z., Wulur I. and, Hedrick M. H. (2006): Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat. Clin. Pract. Cardiovasc. Med., 3 (suppl. 1), S33-37.
17. Gomez-Navarro J., Contreras J. L., Arafat W., Jiang X. L., Krisky D., Oligino T., Marconi P., Hubbard B., Glorioso J. C., Curiel D. T. and Thomas J. M. (2000): Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model. Gene Ther., 7, 43-52.
18. Goon P. K., Boos C. J., Stonelake P. S., Blann A. D. and Lip G. Y. (2006): Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb. Haemost., 96, 45-52.
19. Grisar J., Aletaha D., Steiner C. W., Kapral T., Steiner S., Seidinger D., Weigel G., Schwarzinger I., Wolozcszuk W., Steiner G. and Smolen J. S. (2005): Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation, 111, 204-211.
20. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N. R., Crystal R. G., Besmer P., Lyden D., Moore M. A., Werb Z. and Rafii S. (2002): Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109, 625-637.
21. Herbrig K., Haensel S., Oelschlaegel U., Pistrosch F., Foerster S. and Passauer J. (2006): Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann. Rheum. Dis., 65, 157-163.
22. Hill J. M, Zalos G., Halcox J. P., Schenke W. H., Waclawiw M. A., Quyyumi A. A. and Finkel T. (2003): Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med., 348, 593-600.
23. Hristov M. and Weber C. (2004): Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell Mol. Med., 8, 498-508.
24. Imanishi T., Hano T. and Nishio I. (2005): Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Hypertens Res., 28, 263-271.
25. Imanishi T., Kobayashi K., Hano T. and Nishio I. (2005): Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats. Hypertens Res., 28, 763-772.
26. Ingram D. A., Mead L. E., Moore D. B., Woodard W., Fenoglio A. and Yoder M. C. (2005): Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood, 105, 2783-2786.
27. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., Isner J. M., Asahara T. and Losordo D. W. (2003): Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation, 108, 3115-3121.
28. Kalka C., Masuda H., Takahashi T., Kalka-Moll W. M., Silver M., Kearney M., Li T., Isner J. M. and Asahara T. (2000): Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA, 97, 3422-3427.
29. Kim H. S., Skurk C., Thomas S. R., Bialik A., Suhara T., Kureishi Y., Birnbaum M., Keaney J. F. Jr. and Walsh K. (2002): Regulation of angiogenesis by glycogen synthase kinase-3beta. J. Biol. Chem., 277, 41888-41896.
30. Komarova N. L. and Mironov V. (2005): On the role of endothelial progenitor cells in tumor neovascularization. J. Theor. Biol., 235, 338-349.
31. Kondo T., Hayashi M., Takeshita K., Numaguchi Y., Kobayashi K., Iino S., Inden Y. and Murohara T. (2004): Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler. Thromb. Vasc. Biol., 24, 1442-1447.
32. Kränkel N., Adams V., Linke A., Gielen S., Erbs S., Lenk K., Schuler G. and Hambrecht R. (2005): Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler. Thromb. Vasc. Biol., 25, 698-703.
33. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., Zhang J., Ratajczak J. and Ratajczak M. Z. (2004): CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol., 35, 233-245.
34. Lataillade J. J., Clay D., Dupuy C., Rigal S., Jasmin C., Bourin P. and Le Bousse-Kerdiles M. C. (2000): Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood, 95, 756-768.
35. Laufs U., Urhausen A., Werner N., Scharhag J., Heitz A., Kissner G., Bohm M., Kindermann W. and Nickenig G. (2005): Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur. J. Cardiovasc. Prev. Rehabil., 12, 407-414.
36. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jurgens K., Miche E., Bohm M. and Nickenig G. (2004): Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation, 109, 220-226.
37. Lenk K., Adams V., Lurz P., Erbs S., Linke A., Gielen S., Schmidt A., Scheinert D., Biamino G., Emmrich F., Schuler G. and Hambrecht R. (2005): Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur. Heart J., 26,1903-1909.
38. Liekens S., De Clercq E. and Neyts J. (2001): Angiogenesis: regulators and clinical applications. Biochem. Pharmacol., 61, 253-270.
39. Lonnqvist F., Arner P., Nordfors L. and Schalling M. (1995): Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med., 1, 950-953.
40. Loomans C. J., de Koning E. J., Staal F. J., Rookmaaker M. B., Verseyden C., de Boer H. C., Verhaar M. C., Braam B., Rabelink T. J. and van Zonneveld A. J. (2004): Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 53, 195-199.
41. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verastegui E. and Zlotnik A. (2001): Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
42. Murayama T., Tepper O. M., Silver M., Ma H., Losordo D. W., Isner J. M., Asahara T. and Kalka C. (2002): Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factorinduced neovascularization in vivo. Exp. Hematol., 30, 967-972.
43. Naruse K., Hamada Y., Nakashima E., Kato K., Mizubayashi R., Kamiya H., Yuzawa Y., Matsuo S., Murohara T., Matsubara T., Oiso Y. and Nakamura J. (2005): Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes, 54, 1823-1828.
44. Pistrosch F., Herbrig K., Oelschlaegel U., Richter S., Passauer J., Fischer S. and Gross P. (2005): PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis, 183, 163-167.
45. Pistrosch F., Passauer J., Fischer S., Fuecker K., Hanefeld M. and Gross P. (2004): In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care, 27, 484-490.
46. Rehman J., Li J., Parvathaneni L., Karlsson G., Panchal V. R., Temm C. J., Mahenthiran J. and March K. L. (2004): Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J. Am. Coll. Cardiol., 43, 2314-2318.
47. Rehman J., Li J., Orschell C. M. and March K. L. (2003): Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107, 1164-1169.
48. Risau W. (1997): Mechanisms of angiogenesis. Nature, 386, 671-674.
49. Rotmans J. I., Heyligers J. M., Verhagen H. J., Velema E., Nagtegaal M. M., de Kleijn D. P., de Groot F. G., Stroes E. S. and Pasterkamp G. (2005): In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation, 112, 12-18.
50. Rumpold H., Wolf D., Koeck R. and Gunsilius E. (2004): Endothelial progenitor cells: a source for therapeutic vasculogenesis? J. Cell Mol. Med., 8, 509-518.
51. Sandri M., Adams V., Gielen S., Linke A., Lenk K., Krankel N., Lenz D., Erbs S., Scheinert D., Mohr F. W., Schuler G. and Hambrecht R. (2005): Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation, 111, 3391-3399.
52. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki K., Shimada T., Oike Y. and Imaizumi T. (2001): Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103, 2776-2779.
53. Shyu W. C., Lin S. Z., Chiang M. F., Su C. Y. and Li H. (2006): Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J. Neurosci., 26, 3444-3453.
54. Simper D., Wang S., Deb A., Holmes D., McGregor C., Frantz R., Kushwaha S. S. and Caplice N. M. (2003): Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation, 108, 143-149.
55. Stoll B. R., Migliorini C., Kadambi A., Munn L. L. and Jain R. K. (2003): A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy. Blood, 102, 2555-2561.
56. Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., Laufs K., Ghaeni L., Milosevic M., Bohm M. and Nickenig G. (2003): Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation, 107, 3059-3065.
57. Tepper O. M., Galiano R. D., Capla J. M., Kalka C., Gagne P. J., Jacobowitz G. R., Levine J. P. and Gurtner G. C. (2002): Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 106, 2781-2786.
58. Urbich C. and Dimmeler S. (2004): Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res., 95, 343-353.
59. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A. M. and Dimmeler S. (2003): Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation, 108, 2511-2516.
60. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A. M. and Dimmeler S. (2001): Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res., 89, E1-7.
61. Verma S., Kuliszewski M. A., Li S. H., Szmitko P. E., Zucco L., Wang C. H., Badiwala M. V., Mickle D. A., Weisel R. D., Fedak P. W., Stewart D. J. and Kutryk M. J. (2004): C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation, 109, 2058-2067.
62. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Böhm M. and Nickenig G. (2005): Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med., 353, 999-1007.
63. Wolk R., Deb A., Caplice N. M. and Somers V. K. (2005): Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis, 183, 131-139.
64. Yamamoto K., Kondo T., Suzuki S., Izawa H., Kobayashi M., Emi N., Komori K., Naoe T., Takamatsu J. and Murohara T. (2004): Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler. Thromb. Vasc. Biol., 24, e192-196.
65. Yin A. H., Miraglia S, Zanjani E. D., Almeida-Porada G., Ogawa M., Leary A. G., Olweus J., Kearney J. and Buck D. W. (1997): AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90, 5002-5012.
66. Yu Y., Flint A., Dvorin E. L and Bischoff J. (2002): AC133-2, a novel isoform of human AC133 stem cell antigen. J. Biol. Chem., 277, 20711-20716.